October 8, 2024 10:10 AM EDT
News Briefing

Schol­ar Rock aims to raise $275M; Vin­cerx to reshuf­fle pipeline fo­cus

ENDPOINTS

Plus, news about Vi­core:

Schol­ar Rock seeks $275M in stock sale: Af­ter an­nounc­ing the suc­cess of a piv­otal clin­i­cal tri­al for its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

Pfiz­er's for­mer top ex­ec­u­tives pitched changes to board as part of ac­tivist's plan

Sage faces third study fail in six months as Alzheimer's can­di­date miss­es Phase 2 goal

Astel­las places new bet on gene ther­a­py in $50M up­front deal with UK start­up

Ex­clu­sive: Tiny start­up with big vi­sion to ex­tend healthspan by 20 years says it dis­cov­ered an ‘At­las of ...

J&J’s ‘pret­zel’ drug-de­vice ther­a­py fails in cer­tain blad­der can­cer pa­tients

Ex­clu­sive: Lil­ly backs a16z-fund­ed Ar­da Ther­a­peu­tic­s' $43M Se­ries A to take AD­Cs in­to fi­bro­sis

A service from the Financial Times